Editorial Board ::: Current Gene Therapy

ISSN: 1566-5232 (Print)
ISSN: 1875-5631 (Online)


Volume 16, 6 Issues, 2016


Download PDF Flyer




Current Gene Therapy

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 81st of 167 in Genetics & Heredity

Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Ignacio Anegon
Director INSERM UMR 1064-Center for Research in Transplantation and Immunology
CHU de Nantes. 30, boulevard
Nantes
France


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.738
5 - Year: 3.186

Editorial Board

Editor-in-Chief:

Ignacio Anegon
Director INSERM UMR 1064-Center for Research in Transplantation and Immunology
CHU de Nantes. 30, boulevard
Nantes
France



Founding Editor(s):

Pedro R. Lowenstein
Gene Therapeutics Research Institute
Los Angeles
CA
USA


Deputy Editor(s):

Tuan H. Nguyen
INSERM UMR 1064-Center for Research in Transplantation and Immunology
CHU de Nantes 30, boulevard Jean Monnet 44093
Nantes
France


Associate Editor(s):

L.-J. Chang (Biography
L.-J. Chang

Dr. Chang obtained a doctorate (Ph.D.) in Microbiology from the University of Iowa, Iowa City. Currently Dr. Chang is a tenured Full Professor in University of Florida College of Medicine, and serves as President of Shenzhen Geno-immune Medical Institute (GIMI), Shenzhen, China. He has published more than 130 scientific publications and filed more than 30 US patents. Dr. Chang develops novel molecular biology and gene therapy tools and participates in individualized medical treatments in multiple clinical trials applying gene and cell based therapeutics.

)

University of Florida
Gainesville, FL
USA

P. Cruz
Inst. de Biologia Experimental e Tecnol
Oeiras
Portugal

C. Fillat
IDIBAPS
Barcelona
Spain

H.J. Haisma (Biography
H.J. Haisma

Prof. Haisma earned his Ph.D. in 1987 at the University of Utrecht, The Netherlands. He worked as scientist for the biotech company Centocor Inc. Malvern PA, USA (1985-1986), Dana Farber Cancer Institute, Brigham and Women’s Hospital Boston MA, USA (1986-1987), and as instructor at Harvard Medical School, Boston MA, USA (1986-1987). From 1987-1997. He is a professor at the University of Groningen, The Netherlands.

Haisma is member of the board of the Dutch Society of Gene and Cell Therapy and a former member of the board of the European Society for Gene- and Cell Therapy. In addition, he is member of the Gene and Cell Doping Expert Group of the World Anti-Doping Agency (WADA).

)

University of Groningen
Groningen, PA
The Netherlands

F. Mavilio
University of Modena
Modena
Italy

L. Qiao (Biography
L. Qiao

Dr. Liang Qiao is currently a principal research fellow and an Associate Professor in the Storr Liver Centre at the Westmead Institute for Medical Research, the University of Sydney. Dr. Qiao also serves as an editor for other international journals (Cancer Letters, World J Gastroenterol, Abdomen, Anti-Cancer Agents in Medicinal Chemistry, Anal Cell Pathol, etc.). He regularly reviews manuscripts for several international journals (Oncotarget, Int J Nanomed, J Hepatol, Stem Cell Dev, J Gastroenterol Hepatol, Liver International, etc). He is a member of the European Association for the Study of the Liver (EASL), a member of the Australian Society for Stem Cell Research (ASSCR).

)

The University of Sydney at Westmead Hospital
Australia

M.G. Roncarolo
San Raffaele Telethon Inst. for Gene Therapy
Milan
Italy

F. Yao
Brigham and Women's Hospital
Boston, MA
USA

M. Chuah
Free University of Brussels
Brussels, Belgium
Belgium

D.T. Curiel
University of Alabama
Birmingham, AB
USA

C. Giovannangeli
CNRS
Paris
France

R.G. Hawley
George Washington University Med. Ctr
Washington, DC
USA

P. Moullier
INSERM U649
Nantes
France

F. Rolling
INSERM, U649
Nantes
France

M. Tangney
Cork Cancer Research Centre
Cork
Ireland

J.-P. Concordet
CNRS
Paris
France

R.J. Festenstein
Imperial College London
London
UK

J. Glorioso
University of Pittsburgh
Pittsburgh, PA
USA

Y.-C. Hu (Biography
Y.-C. Hu

Dr. Yu-Chen Hu received his BS degree in Chemical Engineering from National Taiwan University (1992) and earned his PhD degree in Chemical Engineering from University of Maryland (USA) in 1999. Dr. Hu’s main research interests include vaccine development, gene therapy, tissue engineering, cancer therapy and synthetic biology. Dr. Hu has won the Asia Research Award, Outstanding Research Award, BEST Biochemical Engineering Achievement Award, Wu Ta-You Memorial Award (NSC), Outstanding Academia-Industry Research Award and Outstanding Young Investigator Award in Taiwan. He is inducted as a fellow of American Institute for Medical and Biological Engineering (AIMBE), and is elected the Member of the Tissue Engineering International & Regenerative Medicine Society-Asia Pacific (TERMIS-AP) Council and the Vice President of Biotechnology and Biochemical Engineering Society of Taiwan.

)

National Tsing Hua University
Hsinchu
Taiwan

B. Pitard
Inserm 1087/CNRS 6291
Nantes
France

M.-P. Rols
IPBS-CNRS
Toulouse
France

J. Verhaagen
Netherlands Inst. for Brain Res
Amsterdam
The Netherlands


Regional Editor(s):

Region: Australia
Ian E. Alexander
New Children Hospital
Parramatta, NSW
Australia
Region: U.S.A
Maria Castro
University of Michigan Medical School
Ann Arbor, MI
USA
Region: Latin America
Cibele Peroni
Biotechnology Department
IPENCNEN,Cidade Universitària
São Paulo
Brazil
Region: Asia
Toshiyoshi Fujiwara
Department of Gastroenterological Surgery
Okayama University Graduate School of Medicine
Dentistry, and Pharmaceutical Sciences
Okayama
Japan
Region: Europe
Thierry Vandendriessche
Department of Gene Therapy & Regenerative Medicine
Free University of Brussels (VUB)
Leuven
Belgium

Editorial Board Members:

A. Amalfitano
Duke University Medical Center
Durham, NC
USA

P.M. Cannon
University of Southern California
Los Angeles, CA
USA

J.A. Chiorini
National Institutes of Health
Bethesda, MD
USA

D.L. Ennist
DLE Consulting
Bethesda, MD
USA

T.R. Flotte
University of Florida
Gainesville, FL
USA

Z. Ivics (Biography
Z. Ivics

Zoltán Ivics received his PhD in molecular biology from University of Minnesota in the USA and the Netherlands Cancer Institute.He was appointed as Head of Division at the Paul Ehrlich Institute in Langen, Germany, in 2011. He received recognition of the “Molecule of the Year” in 2009 for developing a hyperactive Sleeping Beauty transposase that opened the door for clinical applications. He has been serving as Member of the Board of the European Society of Gene and Cell Therapy (ESGCT) and as a faculty member of the Center for Cell and Gene Therapy of the LOEWE (Landes-Offensive zur Entwicklung Wissenschaftlich-ökonomischer Exzellenz) program in Hessen, Germany.

)

Paul Ehrlich Institute
Langen
Germany

P.D. Kessler
Genvec, Inc.
Gaithesburg, MD
USA

G. Martino (Biography
G. Martino

Dr. Martino received his Medical Degree in 1987 from the Univ. of Pavia where he completed his residency in Neurology in 1991. In 1990, He held the position of Research Associate at the Dept. of Neurology of the Univ. of Chicago. From 1992 to 2008, he worked first as Senior Scientist and then as Director of the Neuroimmunology Unit of the San Raffaele Scientific Institute in Milan, where, from 2008, he acts as Director of the Dept. of Neuroscience. He is full professor of experimental biology at the Univ. Vita-Salute San Raffaele and honorary professor at Queen Mary Univ. of London.

)

San Raffaele Hospital
Milan
Italy

D.A. Muruve
University of Calgary
Calgary, AB
Canada

M. Sadelain
Mem. Sloan-Kettering Cancer Center
New York, NY
USA

R.O. Snyder
University of Florida
Gainesville, FL
USA

S. Ylä-Herttuala
University of Eastern Finland
Kuopio
Finland

J.M. Aran
Molecular Genetics Center-IR
Barcelona
Spain

M.J.T. Carrondo
Inst. de Biologia Experimental e Tecnol
Oeiras
Portugal

O. Cohen-Hagenauer
National university of Cachan
Cachan Cede
France

A.L. Epstein
Université Claude Bernard
Villeurbanne
France

R.E. Hawkins
Christie Hospital NHS Trust
Manchester
UK

A. Kalergis (Biography
A. Kalergis

Dr. Alexis M. Kalergis. He is a Professor at the Schools of Biological Sciences and Medicine of the Pontificia Universidad Católica de Chile. He obtained the Julius Marmur Award for his MSc and PhD work on Microbiology and Immunology at the Albert Einstein College of Medicine. He performed post-doctoral training at the Albert Einstein and The Rockefeller University, supported by the Helen Hay Whitney Foundation. He is the Director of the Millennium Institute on Immunology and Immunotherapy. His research focuses on the molecular interactions regulating the T cell-DC synapse and their contribution to pathogen immunity and self-tolerance during autoimmunity.

)

Pontificia Universidad Católica de Chil
Santiago de Chile
Chile

I. Kovesdi
KILA Consultants
Rockville, MD
USA

J.M. Mathis (Biography
J.M. Mathis

Dr Mathis received his Ph.D. in Biochemistry from the University of Texas Southwestern Medical Center in Dallas. Currently, he is Professor and Department Head of Comparative Biomedical Sciences at Louisiana State University School of Veterinary Medicine. Having published over 100 scientific manuscripts, he has worked in the field of translational cancer research to develop multiple methods of gene and cell therapy, particularly in using adenovirus-based delivery vehicles. In particular, his laboratory has modified capsid proteins on adenovirus vectors for cancer retargeting and molecular imaging, as well as developed adenovirus-based cancer vaccines and conditionally replicating vectors for cancer therapy.

)

Louisiana State University
California, LA
USA

J. Prieto
CIMA University of Navarra
Pamplona
Spain

M. Schmidt
Nationales Zentrum für Tumorerkrankungen (NCT)
Heidelberg
Germany

A.W. Thomson
University of Pittsburgh
Pittsburgh, PA
USA

P. Arbuthnot (Biography
P. Arbuthnot

Patrick Arbuthnot is currently personal professor and director of the Antiviral Gene Therapy Research Unit at the University of the Witwatersrand in Johannesburg, South Africa. After graduating with a medical degree Patrick Arbuthnot completed a PhD in 1992. He then took up a postdoctoral position at Necker Hospital in Paris when he developed an interest in gene therapy for liver cancer and hepatitis B virus (HBV) infection. On returning to South Africa, Patrick Arbuthnot established the Antiviral Gene Therapy Research Unit. The group has published widely on advancing gene therapy-based methods for treatment of HBV and HIV-1 infections.

)

Haematology University of the Witwatersrand
Wits
South Africa

S.H. Cheng
Genzyme Corporation
Framingham, MA
USA

S.L. Eck
Pfizer, Inc
Ann Arbor, MI
USA

Y. Feng
Brigham and Women's Hospital
Boston, MA
USA

R.W. Herzog
University of Florida
Gainesville, FL
USA

J. Kaplan
Genzyme Corporation
Framingham, MA
USA

J. N. Lozier
FDA Ctr. for Biologics Evaluation & Res.
Rockville, MD
USA

R. Morishita
Osaka University Medical School
Osaka
Japan

D.W. Russell
University of Washington
Seattle, WA
USA

S.K. Singh
Centre for Cellular Molecular Biology
Hyderabad
India

M.J. Tiera
UNESP-Instituto de Biociências Letras e Ciências Exatas Av
São Paulo
Brazil


Advertisement
5th ANNUAL ORPHAN DRUGS EVENT

Related Journals




Related eBooks


Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science